Q Fever Risk in Patients Treated with Chronic Antitumor Necrosis Factor-Alpha Therapy
Joint Authors
Hirsch, Julianna
Astrahan, Anna
Odeh, Majed
Elias, Nizar
Rosner, Itzhak
Rimar, Doron
Kaly, Lisa
Rozenbaum, Michael
Boulman, Nina
Slobodin, Gleb
Source
Case Reports in Infectious Diseases
Issue
Vol. 2016, Issue 2016 (31 Dec. 2016), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2016-08-30
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Q fever is a zoonotic bacterial disease caused by Coxiella burnetii.
Tumor necrosis factor-alpha (TNF-α) plays a pivotal role in the defense against infection with this Gram-negative coccobacillus.
Theoretically, patients who are treated with anti-TNF-α medications are at risk for developing chronic Q fever.
We present two patients who developed Q fever while being treated with anti-TNF-α agents and discuss the significance of timely diagnosis of C.
burnetii infection in these patients.
American Psychological Association (APA)
Hirsch, Julianna& Astrahan, Anna& Odeh, Majed& Elias, Nizar& Rosner, Itzhak& Rimar, Doron…[et al.]. 2016. Q Fever Risk in Patients Treated with Chronic Antitumor Necrosis Factor-Alpha Therapy. Case Reports in Infectious Diseases،Vol. 2016, no. 2016, pp.1-3.
https://search.emarefa.net/detail/BIM-1100977
Modern Language Association (MLA)
Hirsch, Julianna…[et al.]. Q Fever Risk in Patients Treated with Chronic Antitumor Necrosis Factor-Alpha Therapy. Case Reports in Infectious Diseases No. 2016 (2016), pp.1-3.
https://search.emarefa.net/detail/BIM-1100977
American Medical Association (AMA)
Hirsch, Julianna& Astrahan, Anna& Odeh, Majed& Elias, Nizar& Rosner, Itzhak& Rimar, Doron…[et al.]. Q Fever Risk in Patients Treated with Chronic Antitumor Necrosis Factor-Alpha Therapy. Case Reports in Infectious Diseases. 2016. Vol. 2016, no. 2016, pp.1-3.
https://search.emarefa.net/detail/BIM-1100977
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1100977
